Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bacteria
Biotech
Salspera plans $91M IPO to fund salmonella-based cancer therapy
Salspera has set out plans for a $91 million IPO to fund the phase 3 study of its bacteria-based cancer therapy.
James Waldron
Mar 11, 2026 6:45am
Lighthouse nabs $49M grant for bacteria-related Alzheimer's test
Aug 22, 2025 8:07am
Harmless skin bacteria engineered to be living topical vaccine
Dec 11, 2024 11:00am
Compounds from bog fungi kill tuberculosis bacteria in the lab
Dec 3, 2024 2:00pm
Free-floating bacterial gene challenges biology's cardinal rules
Aug 14, 2024 10:31am
Mouth microbe on the move may drive colorectal cancer
Mar 25, 2024 3:30pm
